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Insertions in HIV-1 reverse transcriptase's fingers subdomain can enhance chain terminator excision and confer resistance to multiple
nucleoside analogs. Inserts that resemble flanking sequences likely arise by local sequence duplication. However, a remarkable variety of non-
repeat fingers insertions have been observed. Here, molecular epidemiology, sequence analyses and mechanistic modeling were employed to show
that one Japanese isolate's RT fingers insert likely resulted from non-homologous recombination between virus and host sequences and the
transductive copying of 37 nucleotides from human chromosome 17. These findings provide evidence that human sequence transduction can, at
least rarely, contribute to genetic and phenotypic variation in pandemic HIV.
© 2006 Elsevier Inc. All rights reserved.Keywords: Genetic recombination; Retroviruses; Reverse transcriptase; Drug resistanceIntroduction
Much of HIV-1's genetic variation arises by stepwise – albeit
at times hypermutation-accelerated – accumulation of point
mutations (Harris et al., 2003; Leitner and Albert, 1999).
Genetic recombination also contributes to HIV genetic diversity
and occurs about 10-fold more frequently than base substitution
(An and Telesnitsky, 2002; Jetzt et al., 2000). Because fewer
molecular events are required to introduce panels of mutations
by recombination than by serial mutation, clustered genome
changes are generally believed to reflect recombination or
related rearrangements (Malim and Emerman, 2001; Wain-
Hobson et al., 2003). Retroviral recombination results from
template switching during reverse transcription and generally
occurs in regions of high sequence similarity between the two
intact genomes each retrovirus co-packages (An and Tele-
snitsky, 2002). Non-homologous recombination, often guided
by microhomology between donor and acceptor templates, can⁎ Corresponding author. Fax: +1 734 764 3562.
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doi:10.1016/j.virol.2006.05.009also occur (Hajjar and Linial, 1993; Zhang and Temin, 1993).
Deletions and insertions can arise via non-homologous
recombination between discontinuous portions of the viral
genome (Parthasarathi et al., 1995; Temin, 1993). Duplications
result if template switch occurs from one RNA position to a
locus further downstream on the co-packaged RNA, while
deletions arise when reverse transcriptase “jumping” bypasses
sequences and terminates upstream of the point of template
departure (Parthasarathi et al., 1995). Insertion-in-a-deletion or
insertion-in-a-duplication mutations can result from a series of
non-homologous crossovers (Lobato et al., 2002; Parthasarathi
et al., 1995; Pathak and Temin, 1990). Either virus or host
sequences can template insertions, as postulated by models for
oncogene transduction (Muriaux and Rein, 2003). Although
whole gene transduction is rare, incorporation of short host
segments into defective viral genomes is observed fairly
frequently (Dunn et al., 1992; Fang and Pincus, 1995; Hajjar
and Linial, 1993; Mikkelsen and Pedersen, 2000; Pulsinelli and
Temin, 1991; Sun et al., 2001). Thus, experimentally, the use of
host sequences to bridge non-homologous recombination
junctions and the insertion of host segments at strong stop or
non-homologous crossover sites is a well-established
2 Rapid Communicationphenomenon. Possible contributions of host sequences to HIV
clinical isolates has been less clear: both because pre- and post-
mutation sequence data are seldom available and because
inserts maintained in replication-competent virus are generally
too short to implicate a specific template (Winters and Merigan,
2005).
Results
In this report, we examined an unusually lengthy insertion
mutation in an HIV-1 isolate from a Japanese child, with the
goal of elucidating its likely origins (Sato et al., 2001).
Epidemiologic investigation provided sequence information
for the viral populations observed in the patient, referred to as
NH3, during the 6 years prior to and at the onset of clinical
drug resistance. These included the multi-drug-resistant isolate
itself (designated 99JP-NH3-II) and several co-circulating
insertion region variants (Fig. 1A). Additional sequenceFig. 1. Sequence analyses of the 99JP-NH3-II insertion region. (A) Deduced preinser
The NH3 isolates shown are GenBank accession nos. AB053002, AB053074, AB05
AB053003, AB053077, AB053068, AB053058, and AB053083. Numbers at top repr
NH3-II is region of greatest human match. Shaded sequences are positions that differ f
sequences in GenBank. Underlined sequences indicate greatest match to the 51-base
nr GenBank. The human match encompasses an intron/exon junction in AC135178 (C
match lies within CR857769; Bdellovibrio: BX842654, Drosophila: AY183918. Ex
methods. Note that although human and chimpanzee sequences are highly related i
markedly between human and chimpanzee, and thus, no match between the 99JP-NH
panel B: blastn results from nr GenBank limited to viruses, after manual removal of N
AY509253; for Kenyan HIV-1: AF457073.information was available for isolates from NH3's father,
NH1, who had been infected in Thailand, and from his
mother, NH2, who had contracted HIV-1 from NH1 and
subsequently infected NH3 through maternal transmission.
This clinical history confirmed that the insertion arose during
highly active antiretroviral treatment in NH3 (Sato et al.,
2001). A comparison of virus with and without the insert
demonstrated that the 11-amino-acid insertion in the reverse
transcriptase of this CRF001_AE circulating recombinant
form variant contributed to its high-level resistance to
multiple nucleoside analogs.
The region encompassing the 33 nucleotides inserted in
NH3's RT gene was evaluated for similarity to experimentally
described retroviral recombination products. The insertion did
not mirror flanking sequences and thus was not a simple
duplication (Parthasarathi et al., 1995). The entire sequence of
the 99JP-NH3-II genome was available and none of it
resembled the 33-nucleotide insert. Thus, sequential templatetion sequence, sequence insertion in 99JP-NH3-II, and insertion region variants.
3071, AB053005, AB053038, AB053073, AB053065, AB053035, AB053084,
esent amino acid residue numbers within reverse transcriptase. Line under 99JP-
rom 99JP-NH3-II. (B) Comparisons of the 99JP-NH3-II insertion region to other
insertion region of 99JP-NH3-II. At the top (‘All sequences’): blastn results from
hromosome 17 open reading frame 68; also found in NC_00017); the orangutan
pect values at left are those assigned by blastn, as described in Materials and
n the 3′ regions of human chromosome 17 orf 68, the orf 68 5′ region differs
3-II insert and GenBank chimpanzee sequences is detectable. At the bottom of
H3 sequences. Accession number for the circovirus: AY321985; for herpesvirus:
3Rapid Communicationswitches among viral segments could not account for NH3's RT
insert.
Support for possible non-viral origins of the 33-base
insertion came from its striking nucleotide composition.
Whereas typical HIV sequences have a <40% G + C content
(Berkhout et al., 2002), this insert was 67% G + C. Because
abnormal G + C content is a hallmark of horizontal gene transfer
(Hacker and Kaper, 2000), we explored possible human origins
for the insert. If microhomology guided template switch had
contributed to insert generation, viral sequences flanking the
insert would be predicted to retain human sequence homology.
To accommodate this, a 51-base segment comprised of the 33-
base insert plus nine nucleotides from either flank was used in
the database searches summarized in Fig. 1B.
When this 51-base segment was used to query unrestricted
databases in GenBank, the best match was to 99JP-NH3-II
itself, followed closely by the insert variants isolated from NH3
(Fig. 1A). The similarity of these NH3 isolates to one another
and the differences between their inserts and all other HIV
sequences (see below) makes it reasonable to assume that a
single insertion event gave rise to all insert variants in patient
NH3: an interpretation also supported by our previous studies
on viral molecular evolution in NH3 (Sato et al., 2001).
Excluding NH3's HIV strains, the closest GenBank match to
this 51-base sequence was a 30/31-base match to a non-
repetitive sequence on human chromosome 17 (Fig. 1B). This
was followed by a 27/28 match to the orthologous locus in
orangutan, with the remaining top matches including a 20/20
match to the genome of the predatory bacterium Bdellovibrio,
followed by less extensive matches to sequences from
Drosophila, mouse, dog, and rice, but notably not from any
non-NH3 HIV-1 isolates.
To assess similarity of the 99JP-NH3-II insert to sequences
in other HIV isolates, the 51-base segment was subsequently
BLASTed against all virus entries in GenBank (‘Virus
sequences’ in Fig. 1B). Besides 99JP-NH3-II and the co-
circulating isolates from NH3, no viral sequences in GenBank
yielded expect values of <1. Because expect values are
measures of probability roughly equivalent to P values, the
absence of <1 matches in any isolate of any type of virus
suggests that the insert in 99JP-NH3-II is even less similar to
any known virus sequence than would be predicted by random
chance. Whereas BLAST had assigned the 30/31 human
genome match an expect score of 0.00005, the only HIV
match assigned an expect score <10 was a 15/15-base match
(expect score 6.6) to a portion of env in a clinical isolate from
Kenya (Fig. 1B).
That the virus–human match included a few bases
downstream of the insertion was consistent with the possibility
that microhomology guided recombination between HIV-1 and
the BLAST-identified human sequence generated this insertion.
These observations and the mutation's structure suggested that
the NH3 insertion was generated via the splinted non-
homologous recombination model shown in Fig. 2. Briefly, an
HIV-1 provirus was established on chromosome 17 just
upstream of the putative insert-encoding sequences (Fig. 2A).
Viral polyadenylation signal read-through generated a chimericHIV-human RNA that became encapsidated. During subsequent
reverse transcription, microhomology-guided template switch-
ing between portions of the RT gene and human sequences on
the read-through RNA generated the observed insertion-in-a-
duplication structure (Fig. 2B).
This model is based on experimental outcomes of non-
homologous recombination, models for retroviral transduction,
and properties of the putative human bridging template (An and
Telesnitsky, 2002; Mikkelsen and Pedersen, 2000; Muriaux and
Rein, 2003). Specifically, the putative human template straddles
an intron/exon junction that lies in the antisense orientation of a
mapped and verified mRNA encoding a putative protein of
unknown function (Gao et al., 2005; Ota et al., 2004). Thus,
although recombination between viral and unlinked host
sequences has been reported previously (Sun et al., 2001), for
the unspliced antisense sequences in this case, host sequences
were more likely to have become encapsidated on a read-
through transcript than as a free RNA (Muriaux and Rein,
2003).
Because it differs at three nucleotide positions from the
founder strain predicted by our model (Fig. 2C), the postulated
recombination events alone cannot explain the JP-NH3-II RT
insertion mutation. However, the spectra of insert variants
isolated from NH3 differed from one another at up to 4 positions
within the examined sequence interval (Fig. 1A). Thus, these
variants' sequence heterogeneity demonstrates that the extent of
viral diversification required to generate JP-NH3-II's insert
from the putative founder strain indisputably did occur within
patient NH3 after initial insert acquisition. This supports the
notion that JP-NH3-II arose via the mechanism outlined in Figs.
2A and B, followed by the introduction of point mutations at the
positions boxed in Fig. 2C.
Discussion
The findings here analyzed a drug resistance-associated
sequence insertion that is not closely related to sequences in any
other HIV-1 isolate in GenBank. The closest match to this insert
among all sequences in GenBank was to a portion of human
chromosome 17. The structure of this mutation resembles
insertion-within-a-duplication mutations that are well repre-
sented among defective retroviral replication products in the
experimental literature. This insert and its flanking sequences
are so dissimilar from one another that the alternate possibility
for insert generation – local sequence duplication followed by
mutation – can in large part be ruled out because the number of
rare events required to generate the observed structure would far
exceed those required by the postulated splinted recombination
mechanism. Because RT is not known to polymerize more than
a single nucleotide or two without a template, it is likely that all
retroviral insertions longer than a couple of bases are
synthesized using some form of template (Pathak and Temin,
1990; Preston and Dougherty, 1996). Thus, there is no
precedence for de novo generation of a heteropolymeric insert
of this length.
The insert examined in this study was located in RT's β3- β4
hairpin, a region where multiple drug resistance-associated
Fig. 2. Splinted recombination model for human sequence insertion. (A) Proviral insertion and read-through RNA. Not to scale. Boxes indicate HIV-1 long terminal
repeats;Ψ indicates RNA packaging/dimerization signal. Thick lines are DNA; thin lines are RNA. Black lines are viral sequences; shaded lines are human sequences.
Arrows indicate direction of transcription and positions of polyadenylation signals. (B) Template switches postulated to generate 99JP-NH3-II. Shown are two co-
packaged RNAs joined at Ψ, and DNA products of template switching (thick and dotted lines: shaded boxes indicate regions of microhomology between viral and
human sequences). Note that experimental studies have demonstrated that polyadenylation read-through occurs during the synthesis of about 10% of all HIV RNAs
and that even unlinked host sequences can become incorporated in proviruses (Olsen et al., 1990; Sun et al., 2001; An and Telesnitsky, 2004 and references therein).
(C) Genetic differences between 99JP-NH3-II and the predicted founder strain. Arrowheads indicate borders of the 33 base insert; hatched sequences were templated
by microhomology, boxed residues are sites of mutations evoked to generate 99JP-NH3-II from the deduced founder strain.
4 Rapid Communicationinsertions are observed in roughly 1% of the viral strains in
treated HIV/AIDS patients world-wide (Winters and Merigan,
2005). Although a simple duplication of flanking sequences is
sufficient to enhance drug resistance and may be the most
frequent cause of β3- β4 insertions, a wide variety of β3- β4
insert sequences – varying in both length and sequence
composition – have been observed (Winters and Merigan,
2005).
Identifying likely human origins of the duplication-flanked
insert in 99JP-NH3-II was possible because this insert was
unusually lengthy. However, alternate means of searching
reveal that Genbank contains additional examples of direct
repeat-flanked RT insertions, albeit with shorter sequence
regions with uncertain origins (Masquelier et al., 2001; van
der Hoek et al., 2005) (see Materials and methods). Although
these latter inserts are too short for homology searching to
implicate specific sequences, it seems reasonable to postulate
that their synthesis involved either virus or host bridging
templates.
Not surprisingly, when the human genome is used to
query all HIV-1 sequences in GenBank, the few isolates that
appear genuine and contain long (>50 nt) human inserts are
annotated as replication-defective (for example, GenBank
accession no. AY561239; see Materials and methods).
Among replication-competent HIV-1 isolates, the insertswith strongest virus–human match belong to the class of
mutations called AVT codon-rich env variable region
extensions (Kitrinos et al., 2003). The codon bias differences
between these inserts and other HIV-1 sequences, as well as
the similarity of these inserts to repetitive human micro-
satellite sequences, have been described previously (An and
Telesnitsky, 2004; Bosch et al., 1994; Kitrinos et al., 2003).
However, most HIV AVT-rich extensions identified by
BLAST using human query sequences have fewer than 30
contiguous bases of match to the human genome reference
sequence. Assessing possible human origins for these AVT-
rich inserts is complicated by these inserts' genetic plasticity,
the extent of microsatellite variation within the human
population, and the relatively high frequency with which
AVT-rich extensions are observed: leaving open the possi-
bility that some arose via recombination between viral
isolates (Kitrinos et al., 2003; Zhivotovsky et al., 2003).
Nonetheless, observations such as RT β3- β4 inserts that
lack genetically linked regions of sequence identity (Mas-
quelier et al., 2001) and the de novo generation of AVT-rich
extensions during virus replication in tissue culture (Kuh-
mann et al., 2004) suggest that on rare occasions additional
instances of short patch human sequence transduction, like
that reported here for 99JP-NH3-II, may contribute to HIV-1
genetic variation.
5Rapid CommunicationMaterials and methods
Sequences and sequence analysis
Analyses shown were performed using default settings in
nucleotide-nucleotide BLAST (blastn) via NCBI (http://www.
ncbi.nlm.nih.gov). All sequences analyzed in this report were
previously deposited in GenBank. Searches described as
unrestricted databases in GenBank or “nr” were searches of
(all GenBank + RefSeq Nucleotides + EMBL + DDBJ + PDB
sequences). Expect values presented in Fig. 1B are those
assigned by NCBI blastn using default gap and mismatch
penalties.
Additional examples of β3- β4 insert splinted recombinants
(GenBank accession nos. AY877315 and AF315271) men-
tioned in the discussion were identified using blastn by querying
Genbank with an artificial sequence comprised of NH3's
preinsertion sequence (Fig. 1A) modified to contain a β3- β4
insert of arbitrary length (24 b) while applying reduced
mismatch and increased gap penalty values and then by
manually screening isolates for strong epidemiologic support
and structures predicted by splinted recombination.
Methods and findings from querying all HIV sequences in
GenBank with the human genome will be described elsewhere.
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